Veterinary Medicines

C-B-GLUCONAT 24 % PLUS 6 % infuzinis tirpalas arkliams, galvijams, avims, ožkoms ir kiaulėms

Authorised
  • Boric acid
  • Magnesium chloride hexahydrate
  • Calcium gluconate
Download as PDF

Product identification

Medicine name:
C-B-GLUCONAT 24 % PLUS 6 % infuzinis tirpalas arkliams, galvijams, avims, ožkoms ir kiaulėms
Active substance:
  • Boric acid
  • Magnesium chloride hexahydrate
  • Calcium gluconate
Target species:
  • Horse
  • Cattle
  • Sheep
  • Goat
  • Pig
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Boric acid
    6.00
    gram(s)
    /
    100.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    6.00
    gram(s)
    /
    100.00
    millilitre(s)
  • Calcium gluconate
    24.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
    • Cattle
    • Sheep
    • Goat
    • Pig
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/94/0101/001
Date of authorisation status change:

Documents

RV0101.pdf

Lithuanian (PDF)
Published on: 3/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."